Neratinib Completed Phase 2 Trials for Neoplasms / Neoplasms, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00300781Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer